Nonsteroidal progesterone receptor ligands with unprecedented receptor selectivity

Journal of Steroid Biochemistry and Molecular Biology

Volumn 75, Issue 1, 2000, Pages 33-42

  Palmer, Stephen ^a   Campen, Carolyn A ^a   Allan, George F ^a   Rybczynski, Philip ^a   Haynes Johnson, Donna ^a   Hutchins, Amy ^a   Kraft, Patricia ^a   Kiddoe, Margaret ^a   Lai, Muh Tsann ^a   Lombardi, Elizabeth ^a   Pedersen, Phyllis ^a   Hodgen, Gary ^b   Combs, Donald W ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Nonsteroidal progesterone receptor ligands; Receptor selectivity; Tetrahydropyridazines

Indexed keywords

LIGAND; PROGESTERONE RECEPTOR; RWJ 26819; TETRAHYDROPYRIDAZINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SPECIFICITY; DRUG SYNTHESIS; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MONKEY; NONHUMAN; OVULATION INHIBITION; RABBIT; RECEPTOR AFFINITY; RECEPTOR SENSITIVITY;

ALKALINE PHOSPHATASE; ANIMALS; BREAST NEOPLASMS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; ENDOMETRIUM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITORY CONCENTRATION 50; LEVONORGESTREL; MACACA FASCICULARIS; MIFEPRISTONE; OVULATION; PIPERAZINES; PIPERIDINES; PROGESTERONE; PROTEIN BINDING; PYRIDAZINES; RABBITS; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RECEPTORS, GLUCOCORTICOID; RECEPTORS, PROGESTERONE; SUBSTRATE SPECIFICITY; TUMOR CELLS, CULTURED;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0034484857     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(00)00134-5     Document Type: Article

References (26)

1. Progestins in the menopause
2. Amenorrhea and breakthrough bleeding associated with contraceptive use
3. Contraceptive potential of RU 486 by ovulation inhibition: I. Pituitary versus ovarian action with blockade of estrogen-induced endometrial proliferation
4. Preliminary report on the treatment of endometriosis with low-dose mifepristone (RU 486)
5. Regression of uterine leiomyomata in response to the anti-progesterone RU-486
6. Eye drops of RU 486-6, a peripheral steroid blocker, lower intraocular pressure in rabbits
7. Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486
8. The antiglucocorticoid action of mifepristone
9. Novel ligands of steroid hormone receptors
10. Casodex: Preclinical studies and controversies
11. Nonsteroidal progesterone receptor ligands. 1. 3-Aryl-1-benzoyl-1,4,5,6-tetrahydropyridazines
12. Nonsteroidal progesterone receptor ligands. 2. High-affinity ligands with selectivity for bone cell progesterone receptors
13. Induction of a novel conformation in the progesterone receptor by ZK299 involves a defined region of the carboxyl-terminal tail
14. Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation
15. The assay of progestin
16. Differential effects of estradiol-17β and progesterone on the proliferation of glandular and luminal cells of rabbit uterine epithelium
17. Contraceptive potential of RU 486 by ovulation inhibition: I. Pituitary versus ovarian action with blockade of estrogen-induced endometrial proliferation
18. In vitro growth promotion of human mammary carcinoma cells by steroid hormones, tamoxifen, and prolactin
19. Progestin effects on growth in the human breast cancer cell line T-47D-possible therapeutic implication
20. Human progesterone receptor complexed with the antagonist RU 486 binds to hormone response elements in a structurally altered form
21. Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins
22. Synthesis and biological activity of novel nonsteroidal progesterone receptor antagonists based on cyclocymopol monomethyl ether
23. Atomic structure of progesterone complexed with its receptor
24. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
25. Discovery and preliminary SAR studies of a novel, nonsteroidal progesterone receptor antagonist pharmacophore